Gainers
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Gracell Biotechnologies Inc (NASDAQ:GRCL) announced the updated clinical data on GC012F, an autologous CAR-T therapeutic candidate dual-targeting B-cell maturation antigen (BCMA)…
Cantor Fitzgerald analyst Louise Chen initiates coverage on Gracell Biotechnologies (NASDAQ:GRCL) with a Overweight rating and announces Price Target of $20.
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Gracell Biotechnologies (NASDAQ:GRCL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement.
Analysts estimate that Gracell Biotechnologies will report an earnings per share (EPS) of $-0.21.
Gracell to present longer-term follow-up clinical data evaluating GC012F, an autologous CAR-T therapeutic candidate dual-targeting BCMA and CD19, for the treatment of relapsed/refractory multiple myeloma
SAN DIEGO,